Clinical Trials Related to Myelodysplastic Syndromes

Related studies linked through entity extraction aliases.

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Status: COMPLETED
Phase: PHASE1/PHASE2

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Status: TERMINATED
Phase: NA

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

Status: COMPLETED
Phase: PHASE2

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Status: RECRUITING
Phase: N/A

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes

Status: TERMINATED
Phase: PHASE1

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Status: COMPLETED
Phase: N/A

A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome

Status: COMPLETED
Phase: PHASE1

Pilot Study of Unrelated Cord Blood Transplantation

Status: TERMINATED
Phase: PHASE2

Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin

Status: TERMINATED
Phase: PHASE2

Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities

Status: COMPLETED
Phase: PHASE2

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

Status: TERMINATED
Phase: PHASE2

Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases

Status: COMPLETED
Phase: N/A

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Status: COMPLETED
Phase: N/A

Collecting and Storing Blood Samples From Patients With Cancer

Status: WITHDRAWN
Phase: N/A

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Status: TERMINATED
Phase: N/A

Studying Fentanyl in Patients With Cancer

Status: TERMINATED
Phase: N/A

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

Status: COMPLETED
Phase: N/A

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

Status: COMPLETED
Phase: N/A

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Status: UNKNOWN
Phase: N/A

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

Status: UNKNOWN
Phase: N/A